Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text: the company, which did not admit liability or fault in the settlement
Simplified Text: Abbott Laboratories did not admit liability or fault as part of its settlement.
Confidence Score: 1.000
Claim Maker: The author
Context Type: News Article
Context Details: { "event": "Settlement", "detail": "No admission of liability or fault", "company": "Abbott Laboratories" }
Subject Tags: Business Law
UUID: f5ec3bcd-4107-41e1-bba6-662f1716cbb1
Vector Index: ✗ No vector
Created: September 18, 2026 at 2:01 AM (3 weeks ago)
Last Updated: September 18, 2026 at 2:01 AM (3 weeks ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://nytimes.com/2026/09/14/well/abbott-settlement-infant-formula.html

Abbott to Pay $385 Million to Settle Infant Formula Allegations

Completed News

12 claims 🔥

3 weeks ago

https://nytimes.com/2026/09/14/well/abbott-settlement-infant-formula.html

Abbott Laboratories will pay nearly $385 million to settle claims that it knowingly sold infant formula manufactured in facilities that did not meet safety requirements. This follows a 2022 recall linked to serious illnesses in babies and a nationwide formula shortage.

Infant Formula Abbott Laboratories Product Safety Recalls Justice Department Public Health

Similar Claims (5)

Other claims identified as semantically similar to this one.

The settlement, announced on Monday by the Justice Department, follows years of scrutiny of a plant Abbott managed in Sturgis, Mich. 1.000

Simplified: The Justice Department announced the settlement with Abbott Laboratories on Monday, September 14, 2026.

3 weeks ago
Abbott Laboratories, the maker of the popular infant formula Similac, will pay nearly $385 million to settle claims that it knowingly sold formula manufactured in facilities that did not meet safety r... 1.000

Simplified: Abbott Laboratories will pay nearly $385 million to settle claims of selling formula from facilities that did not meet safety requirements.

3 weeks ago
In a 2022 consent decree reached with the Justice Department, Abbott agreed to replace the plant’s roof, address sanitation protocols and take other corrective steps, though it did not admit liability... 1.000

Simplified: In a 2022 consent decree with the Justice Department, Abbott agreed to replace its plant's roof and address sanitation, without admitting liability.

3 weeks ago
Nearly $349 million of the Abbott settlement funds will go to the federal government and just over $36 million will go to state Medicaid and W.I.C. programs that purchased Abbott’s formula. 1.000

Simplified: Of the Abbott settlement, nearly $349 million will go to the federal government and over $36 million to state Medicaid and W.I.C. programs.

3 weeks ago
Three whistle-blowers who first filed complaints about the plant will receive $69 million. 1.000

Simplified: Three whistle-blowers who filed the initial complaints about the Abbott plant will receive $69 million from the settlement.

3 weeks ago